Royalty Pharma

Royalty Pharma to Pay Potential $500M for Royalties on Ferring’s Gene Therapy
Royalty Pharma to Pay Potential $500M for Royalties on Ferring’s Gene Therapy
BioSpace
Ferring Pharmaceuticals
Royalty Pharma
gene therapy
bladder cancer
Flag link:
Biopharma Companies with the Biggest CEO-Employee Pay Gaps
Biopharma Companies with the Biggest CEO-Employee Pay Gaps
BioSpace
Pharma CEOs
executive compensation
Sarepta Therapeutics
Pfizer
Bausch + Lomb
Amneal Pharmaceuticals
Thermo Fisher
IQVIA
McKesson
Royalty Pharma
Charles Rivers Laboratories
Seagen
Flag link:
Royalty Pharma hands off $100M upfront for PureTech royalty on Karuna's schizophrenia hopeful
Royalty Pharma hands off $100M upfront for PureTech royalty on Karuna's schizophrenia hopeful
Endpoints
Royalty Pharma
Karuna Therapeutics
KarXT
schizophrenia
PureTech
Flag link:
Royalty Pharma nabs $475M milestone from Pfizer upon migraine nasal spray OK
Royalty Pharma nabs $475M milestone from Pfizer upon migraine nasal spray OK
Endpoints
Pfizer
migraines
Royalty Pharma
Biohaven
zavegepant
Flag link:
Royalty Pharma bets Merck's schizophrenia drug can go where Pfizer, Takeda and Lundbeck's couldn’t
Royalty Pharma bets Merck's schizophrenia drug can go where Pfizer, Takeda and Lundbeck's couldn’t
Endpoints
Merck
Royalty Pharma
schizophrenia
MK-8189
Flag link:
Unpacking Royalty Pharma
Unpacking Royalty Pharma
EP Vantage
Royalty Pharma
Ultragenyx
Flag link:
Theravance gets a fresh start
Theravance gets a fresh start
EP Vantage
Theravance
GSK
Trelegy Ellipta
Royalty Pharma
Flag link:
BioCryst gets massive cash infusion to the tune of $350M, thanks to old and new investors
BioCryst gets massive cash infusion to the tune of $350M, thanks to old and new investors
Endpoints
Biocryst
Royalty Pharma
BCX9930
Flag link:
GlaxoSmithKline offloads royalty rights for 2 cancer drugs in $342M windfall it will use to finance consumer spinoff
GlaxoSmithKline offloads royalty rights for 2 cancer drugs in $342M windfall it will use to finance consumer spinoff
Endpoints
GSK
Cabometyx
Cometriq
Royalty Pharma
Flag link:
Biohaven adds nearly $1B in Nurtec deals with Royalty Pharma, Sixth Street
Biohaven adds nearly $1B in Nurtec deals with Royalty Pharma, Sixth Street
Endpoints
Biohaven
Nurtec
Royalty Pharma
Sixth Street
Flag link:
What pandemic? Biotech floats break records
What pandemic? Biotech floats break records
EP Vantage
biotech
IPOs
ADC Therapeutics
Akouos
Applied Molecular Transport
Avidity Biosciences
Ayala Pharmaceuticals
Forma Therapeutics
Fusion Pharmaceuticals
Generation Bio
Hyloris Pharmaceuticals
Lantern Pharma
ORIC Pharmaceuticals
Pliant Therapeutics
PolyPid
Repare Therapeutics
Royalty Pharma
SutroVax
Flag link:
Meet the Pharma Company That Just Had a Bigger IPO Than Moderna's
Meet the Pharma Company That Just Had a Bigger IPO Than Moderna's
Motley Fool
IPOs
Moderna Therapeutics
Royalty Pharma
Flag link:
The biotech IPOs keep coming at chart-topping levels — with no slowdown in sight
The biotech IPOs keep coming at chart-topping levels — with no slowdown in sight
Endpoints
biotech
IPOs
Repare Therapeutics
Forma Therapeutics
Avidity Biosciences
Vaxcyte
SK Biopharmaceuticals
Generation Bio
Royalty Pharma
Flag link:
Royalty Pharma scores $2.2B IPO — the biggest of the year
Royalty Pharma scores $2.2B IPO — the biggest of the year
Endpoints
Royalty Pharma
IPOs
NASDAQ
Flag link:
Royalty Pharma plans largest IPO of the year so far
Royalty Pharma plans largest IPO of the year so far
Pharmaforum
Royalty Pharma
IPOs
NASDAQ
Flag link:
Royalty Pharma buys royalties on Vertex Pharma drugs for $3.3 bln
Royalty Pharma buys royalties on Vertex Pharma drugs for $3.3 bln
Yahoo/Reuters
Royalty Pharma
Vertex Pharma
cystic fibrosis
Flag link:
Game may not be over for Royalty' Pharma's bid for Elan
Game may not be over for Royalty' Pharma's bid for Elan
Reuters
M&A
Elan
Royalty Pharma
Mylan
Allergan
Endo Health Solutions
Forest Labs
Flag link:
Royalty Pharma lets takeover bid for drugmaker Elan expire, decides against court challenge
Royalty Pharma lets takeover bid for drugmaker Elan expire, decides against court challenge
Yahoo/AP
Elan
M&A
Royalty Pharma
Flag link:
Elan Shareholder Vote Nixes Royalty Pharma Takeover -- For Now
Elan Shareholder Vote Nixes Royalty Pharma Takeover -- For Now
TheStreet.com
Elan
M&A
Royalty Pharma
Flag link:
Elan Inviting Royalty Pharma Bid Shows Hostility Easing
Elan Inviting Royalty Pharma Bid Shows Hostility Easing
Bloomberg
Elan
Royalty Pharma
M&A
Flag link:

Pages